Is nuclear imaging a viable alternative technique to assess dyssynchrony?

Area of Science:

• Cardiology
• Medical Imaging
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) benefits selected heart failure (HF) patients with specific criteria (NYHA class III-IV, low ejection fraction, prolonged QRS).
• A significant portion of eligible patients do not respond to CRT, highlighting the need for better patient selection.
• Left ventricular (LV) mechanical dyssynchrony predicts CRT response, but current echocardiography methods lack standardization and reproducibility for routine clinical use.

Purpose of the Study:

• To review and highlight the potential of electrocardiogram-gated single-photon emission computed tomography (SPECT) phase analysis for assessing LV dyssynchrony.
• To propose SPECT phase analysis as a more reliable and reproducible alternative to echocardiography for predicting CRT response in HF patients.

Main Methods:

• Review of existing literature and techniques for assessing LV dyssynchrony.
• Focus on electrocardiogram-gated SPECT myocardial perfusion imaging and its phase analysis capabilities.
• Comparison of SPECT phase analysis with echocardiographic techniques like tissue Doppler imaging (TDI) and strain-rate imaging.

Main Results:

• Echocardiographic techniques for LV dyssynchrony assessment are not yet ready for routine clinical practice due to variability.
• SPECT phase analysis can measure LV dyssynchrony from standard myocardial perfusion imaging without additional procedures.
• SPECT phase analysis offers automation, repeatability, and reproducibility advantages over current echocardiographic methods.

Conclusions:

• There is a critical need for improved, standardized tools to assess LV dyssynchrony for CRT response prediction.
• Electrocardiogram-gated SPECT phase analysis presents a promising, robust, and reproducible method for evaluating LV dyssynchrony.
• This technique has the potential to significantly enhance the prediction of CRT response in heart failure patients.